01 ESOMEPRAZOLE MAGNESIUM; NAPROXEN (2)
01 HORIZON (2)
01 TABLET, DELAYED RELEASE;ORAL (2)
01 EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (2)
19
Horizon Therapeutics, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ESOMEPRAZOLE MAGNESIUM; NAPROXEN, with a corresponding application number 22511 and regulatory information .
proudly manufactured in the
approval since 2010-04-30
Horizon Therapeutics's VIMOVO TABLET, DELAYED RELEASE;ORAL, medication with EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ESOMEPRAZOLE MAGNESIUM; NAPROXEN.
18
Horizon Therapeutics, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ESOMEPRAZOLE MAGNESIUM; NAPROXEN, with a corresponding application number 22511 and regulatory information .
proudly manufactured in the
approval since 2010-04-30
Horizon Therapeutics's VIMOVO TABLET, DELAYED RELEASE;ORAL, medication with EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ESOMEPRAZOLE MAGNESIUM; NAPROXEN.